Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/20/17 → 7/20/20 |
Funding
- Medpace, Inc. (Protocol ALN-TTR02-007 // Protocol ALN-TTR02-007)
- Alnylam Pharmaceuticals, Inc. (Protocol ALN-TTR02-007 // Protocol ALN-TTR02-007)
Protocol ALN-TTR02-007: Expanded Access Protocol of Patisiran for Patients with Hereditary Transthyretin-Mediated Amyloidosis (hATTR Amyloidosis) With Polyneuropathy
- Ajroud-Driss, Senda (PD/PI)
Project: Research project